Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years.

Mendez I, Viñuela A, Astradsson A, Mukhida K, Hallett P, Robertson H, Tierney T, Holness R, Dagher A, Trojanowski JQ, Isacson O.

Nat Med. 2008 May;14(5):507-9. doi: 10.1038/nm1752. Epub 2008 Apr 6.

2.

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW.

Nat Med. 2008 May;14(5):504-6. doi: 10.1038/nm1747. Epub 2008 Apr 6.

PMID:
18391962
3.

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, Widner H, Revesz T, Lindvall O, Brundin P.

Nat Med. 2008 May;14(5):501-3. doi: 10.1038/nm1746. Epub 2008 Apr 6.

PMID:
18391963
4.

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, et al.

N Engl J Med. 1995 Apr 27;332(17):1118-24.

5.

Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice.

Bye CR, Thompson LH, Parish CL.

Exp Neurol. 2012 Jul;236(1):58-68. doi: 10.1016/j.expneurol.2012.04.002. Epub 2012 Apr 16.

PMID:
22524988
6.

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L, Dagher A, Isacson O.

Brain. 2005 Jul;128(Pt 7):1498-510. Epub 2005 May 4.

7.

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.

Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW.

Mov Disord. 1998 May;13(3):383-93.

PMID:
9613726
8.

Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates.

Sladek JR Jr, Collier TJ, Elsworth JD, Roth RH, Taylor JR, Redmond DE Jr.

Cell Transplant. 1998 Mar-Apr;7(2):87-96.

PMID:
9588591
9.

Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients.

Redmond DE Jr, Robbins RJ, Naftolin F, Marek KL, Vollmer TL, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, et al.

Res Publ Assoc Res Nerv Ment Dis. 1993;71:325-59. No abstract available.

PMID:
8417471
11.

Survival of dopaminergic neurons in fetal-tissue grafts.

Hoffer BJ, van Horne C.

N Engl J Med. 1995 Apr 27;332(17):1163-4. No abstract available.

PMID:
7700292
12.

Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S.

N Engl J Med. 2001 Mar 8;344(10):710-9.

14.

Neural transplantation for the treatment of Parkinson's disease.

Björklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, Levivier M, Peschanski M, Studer L, Barker R.

Lancet Neurol. 2003 Jul;2(7):437-45. Review. No abstract available.

PMID:
12849125
15.

Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy.

Brundin P, Kordower JH.

Prog Brain Res. 2012;200:221-41. doi: 10.1016/B978-0-444-59575-1.00010-7. Review.

PMID:
23195421
17.

Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.

Cooper O, Astradsson A, Hallett P, Robertson H, Mendez I, Isacson O.

J Neurol. 2009 Aug;256 Suppl 3:310-6. doi: 10.1007/s00415-009-5242-z. Review.

PMID:
19711122
18.
19.

Encapsulated cell implantation for Parkinson's disease.

Christenson L, Emerich DF, Sanberg PR.

Mov Disord. 1992;7(2):185-6. No abstract available.

PMID:
1584240
20.

The future of cell-based transplantation therapies for neurodegenerative disorders.

Lazic SE, Barker RA.

J Hematother Stem Cell Res. 2003 Dec;12(6):635-42. Review.

PMID:
14977473

Supplemental Content

Support Center